Second Annual Global Champions of Change Competition Winner

MMS has just concluded its second annual Global Champions of Change Competition (G3C), where colleagues from all MMS regions submitted innovative ideas based on our tradition of providing high-quality, efficient services to our clients to help discover and market life-changing medicines to patients around the world.  

Innovation is not new to MMS, we have designed our culture from the beginning to constantly strive for new and better ways to produce quality with efficiency. The G3C competition was created two years ago as a formal way to spark the sharing of innovative ideas from colleagues throughout the entire organization in a competitive but fun environment.  

This year’s G3C winner is Amanda Beaster, Senior Manager of Regulatory Strategy, for her submission of a tool to address labeling deficiencies in the pharmaceutical industry.  

The second-place winners are Audelia Munguia, Director of Safety Risk Management; Susan Mitcheson, Senior Safety Writer; Jeff Wiese, Technical Manager of Safety Writing; and Katrina O’Connor, Senior Medical Writer, for their submission aimed to enhance efficiencies and quality in aggregate reports.  

Thirty-one teams entered this year’s competition, and five teams were chosen to proceed to the final presentation round, with our global colleagues voting for the winner. All 31 entries are evaluated and considered for future implementation.  

Other submissions included ideas that included automation, improving processes, data visualization, supporting rare diseases, improving quality, and concepts relating to MMS technologies such as our TrialAssure Transparency Suite and Datacise.  

MMS believes that innovation comes directly from our colleagues at every level of the organization because those working in our services lines daily see the best opportunities for improvement, and are encouraged to bring those ideas forward. That’s why we often say that “innovation is a company sport”. The G3C competition is not the only time our colleagues can bring innovative ideas forward, and MMS colleagues are encouraged to submit their ideas for improvement throughout the year.   

We are so proud of our colleagues and the effort, energy, and excitement they exhibited during this competition and through their work on a daily basis.  

By Jim Balcom, Director of Partnerships and IT Governance 

Learn more and explore MMS career opportunities here.  

Contact us to speak with Jim Balcom to learn more about innovation.  

Suggested For You

perspectives

September 30th, 2024

Meet the Leaders Driving MMS’s European Growth

perspectives

September 30th, 2024

The Future of Data Management and Biostatistics: Trends and Technologies Shaping the Industry

perspectives

September 24th, 2024

Embracing Quality Management Maturity (QMM) at the Cornerstone of the Pharmaceutical Industry

perspectives

September 11th, 2024

From Historical Precedent to Modern Approvals: Lessons Learned on OTC Drug Products for FDA OMORs

perspectives

September 4th, 2024

Email Security – Navigating Through the Process of Validation and Compliance with Healthcare Business Stakeholders

perspectives

August 27th, 2024

Optimizing Oncology Drug Development: FDA Expedited Pathways, Real-Time Review, and Global Programs

perspectives

August 20th, 2024

Clinical Study Protocols: A Comprehensive Guide to Best Practices From A Senior Medical Writer

perspectives

August 13th, 2024

How To Navigate The Nonclinical Evaluation Landscape Of Biopharmaceuticals

perspectives

August 5th, 2024

Ensuring Robust Data Privacy and Protection: An Overview of the MMS Framework

perspectives

July 30th, 2024

The Critical Role of Quality Control (QC) – Medical Writing and Beyond

perspectives

July 23rd, 2024

PSI 2024 Ignited Conversations on External Data Sources, Requirements for Estimands, and Bayesian Methodology for Statisticians in Pharma

perspectives

July 16th, 2024

Key Steps to Successful CMC Authoring of IND and IMPD Submissions